Dilaudid 8mg – The Complete Medical Guide
Introduction to Dilaudid 8mg
Dilaudid 8mg (hydromorphone hydrochloride) is a high-potency opioid analgesic classified as a Schedule II controlled substance. As one of the strongest commercially available oral opioid formulations, it’s approximately 5-7 times more potent than morphine milligram-for-milligram. This high-dose tablet is reserved for severe, refractory pain in opioid-tolerant patients, typically in cancer pain management or end-of-life care.
Dilaudid 8 mg
Medical Uses & Indications
FDA-Approved Uses
✅ Severe chronic pain management (Cancer-related, palliative care)
✅ Acute pain (Major trauma, post-surgical when other opioids fail)
✅ Breakthrough pain episodes (In opioid-tolerant patients)
Key Clinical Features
• Potency: 5-7× morphine (oral)
• Onset/Duration:
Oral: 30 min onset, 3-4 hr duration
IV: 5 min onset, 2-3 hr duration
• DEA Classification: Schedule II (High abuse potential)
Pharmacology & Effects
Mechanism of Action
• Pure μ-opioid receptor agonist
• Minimal active metabolites (unlike morphine)
Therapeutic Effects
✔ Rapid, powerful analgesia
✔ Reduced affective pain component
✔ Mild anxiolysis in terminal patients
Abuse Potential
• Street names: Dust, Footballs, Smack
• Common routes of abuse: Injection, snorting
• Overdose risk: Extreme with non-tolerant users
Dosing & Administration
Standard Dosing
• Opioid-tolerant adults: 2-8mg every 3-4 hours PRN
• Maximum recommended: 32mg/day (oral)
Conversion Guidelines
| From | Equivalent Dose |
|---|---|
| Morphine 30mg PO | Dilaudid 6mg PO |
| Oxycodone 20mg PO | Dilaudid 4mg PO |
| Fentanyl 100mcg IV | Dilaudid 1.5mg IV |
Critical Safety Notes
⚠ Absolute contraindication in opioid-naïve patients
⚠ Must titrate carefully in renal impairment
⚠ Tablets should never be crushed/chewed
Safety Profile
Common Side Effects
• Respiratory depression (dose-dependent)
• Severe constipation (prophylaxis required)
• Nausea/vomiting
• CNS depression
Black Box Warnings
❌ Life-threatening respiratory depression
❌ Accidental ingestion risk
❌ Addiction/dependence potential
❌ Neonatal opioid withdrawal syndrome
Overdose Management
Recognition
• Respiratory rate <8
• Pinpoint pupils
• Unresponsiveness
• Cyanosis
Emergency Protocol
Administer naloxone (0.4-2mg IV/IM/IN)
Support ventilation
Repeat naloxone q2-3min PRN
Continuous monitoring (may require infusion)
Harm Reduction Strategies
Locked storage (Prevents diversion)
Naloxone co-prescribing (Mandatory in many states)
Medication disposal systems
Regular PDMP monitoring
Clinical Alternatives
For Chronic Pain
• Methadone (For opioid rotation)
• Fentanyl patches (Stable blood levels)
• Buprenorphine (Safer profile)
For Acute Pain
• Oxycodone CR
• Morphine sulfate ER
• Multimodal analgesia




Reviews
There are no reviews yet.